Thirunavukarasu Deepak, Shi Hua
Department of Biological Sciences and the RNA Institute, University at Albany, State University of New York , Albany, New York.
Nucleic Acid Ther. 2015 Apr;25(2):103-12. doi: 10.1089/nat.2014.0510. Epub 2015 Feb 5.
The highly conserved and ubiquitous molecular chaperone heat shock protein 70 (Hsp70) plays a critical role in protein homeostasis (proteostasis). Controlled by its ATPase activity, Hsp70 cycles between two conformations, Hsp70-ATP and Hsp70-ADP, to bind and release its substrate. Chemical tools with distinct modes of action, especially those capable of modulating the ATPase activity of Hsp70, are being actively sought after in the mechanistic dissection of this system. Here, we report a conformation-specific RNA aptamer that binds only to Hsp70-ATP but not to Hsp70-ADP. We have refined this aptamer and demonstrated its inhibitory effect on Hsp70's ATPase activity. We have also shown that this inhibitory effect on Hsp70 is independent of its interaction with the Hsp40 co-chaperone. As Hsp70 is increasingly being recognized as a drug target in a number of age related diseases such as neurodegenerative, protein misfolding diseases and cancer, this aptamer is potentially useful in therapeutic applications. Moreover, this work also demonstrates the feasibility of using aptamers to target ATPase activity as a general therapeutic strategy.
高度保守且普遍存在的分子伴侣热休克蛋白70(Hsp70)在蛋白质稳态(蛋白质平衡)中起着关键作用。受其ATP酶活性控制,Hsp70在两种构象之间循环,即Hsp70-ATP和Hsp70-ADP,以结合并释放其底物。在对该系统的机制剖析中,人们正在积极寻找具有不同作用模式的化学工具,尤其是那些能够调节Hsp70的ATP酶活性的工具。在此,我们报道了一种构象特异性RNA适配体,它仅与Hsp70-ATP结合,而不与Hsp70-ADP结合。我们对该适配体进行了优化,并证明了其对Hsp70的ATP酶活性具有抑制作用。我们还表明,这种对Hsp70的抑制作用与其与Hsp40共伴侣的相互作用无关。由于Hsp70在诸如神经退行性疾病、蛋白质错误折叠疾病和癌症等多种与年龄相关的疾病中越来越被视为药物靶点,这种适配体在治疗应用中可能具有潜在用途。此外,这项工作还证明了使用适配体靶向ATP酶活性作为一种通用治疗策略的可行性。